{"id":"W3112891931","doi":"10.2174/1574886315999201208212356","title":"Efficacy and Cardiovascular Safety of GLP-1 Receptor Analogues","year":2020,"lang":"en","type":"review","venue":"Current Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University","funders":"","keywords":"Semaglutide; Medicine; Lixisenatide; Dulaglutide; Exenatide; Liraglutide; Tolerability; Type 2 diabetes; Incretin; Glucagon-like peptide 1 receptor; Pharmacology; Empagliflozin; Clinical trial; Adverse effect; Diabetes mellitus; Internal medicine; Endocrinology; Receptor; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000410802,0.0006010558,0.003668174,0.000201402,0.00006535219,0.00001618485,0.0002012117,0.0001350869,0.0001196239],"category_scores_gemma":[0.0001032565,0.0004500393,0.001537669,0.0004313225,0.000131279,0.00005352131,0.0002835548,0.0003816009,0.0001505711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001605046,"about_ca_system_score_gemma":0.0001725758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006044694,"about_ca_topic_score_gemma":6.743722e-7,"domain_scores_codex":[0.9973482,0.0002059711,0.0009009581,0.0007328334,0.0004745503,0.0003375229],"domain_scores_gemma":[0.9984089,0.0001645794,0.0002945386,0.0007785588,0.00006929982,0.000284127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006659385,0.0001993632,0.00002580713,0.03067166,0.00423158,0.00001378102,0.00008009367,3.663224e-7,5.544033e-8,0.0002236563,0.006204673,0.9582824],"study_design_scores_gemma":[0.001814483,0.0001012211,0.00008993309,0.01717735,0.01260026,0.000004521054,0.00001845086,0.000002186628,9.721853e-7,0.000004480395,0.9678614,0.0003247023],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000005901205,0.9940262,0.00004885233,0.0001117432,0.000729809,0.002373137,0.0002683564,0.00009147291,0.002344481],"genre_scores_gemma":[0.00001954852,0.99682,0.0001892113,0.00001562764,0.0004121541,0.00006813736,0.002097968,0.00006767142,0.000309722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9616567,"threshold_uncertainty_score":0.9997951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04296746936968761,"score_gpt":0.3165847961124936,"score_spread":0.273617326742806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}